Consistently, the BRIP1 ‘GGG’ haplotype was still significantly associated with a reduced risk of HCC risk (odds ratio, 0.18; 95% CI, 0.05 to 0.59; P=4.16×10−3). This evidence concerns the gene BRIP1 and hepatocellular carcinoma.